ESMO–EURACAN Clinical Practice Guideline update for nasopharyngeal carcinoma: adjuvant therapy and first-line treatment of recurrent/metastatic disease

ESMO Guidelines Committee

doi:10.1016/j.annonc.2022.11.011

ESMO–EURACAN Clinical Practice Guideline update for nasopharyngeal carcinoma: adjuvant therapy and first-line treatment of recurrent/metastatic disease

ESMO Guidelines Committee

Résultats de recherche: Contribution à un journal › Article › Revue par des pairs

21 Citations (Scopus)

langue originale	Anglais
Pages (de - à)	247-250
Nombre de pages	4
journal	Annals of Oncology
Volume	34
Numéro de publication	3
Les DOIs	https://doi.org/10.1016/j.annonc.2022.11.011
état	Publié - 1 mars 2023
Modification externe	Oui

Accès au document

10.1016/j.annonc.2022.11.011

Autres fichiers et liens

Lien vers la publication dans Scopus

Contient cette citation

@article{ed2335fa7cff48d1bdf072e3d3ccd3e1,

title = "ESMO–EURACAN Clinical Practice Guideline update for nasopharyngeal carcinoma: adjuvant therapy and first-line treatment of recurrent/metastatic disease",

keywords = "adjuvant, capecitabine, Clinical Practice Guideline, immunotherapy, nasopharyngeal carcinoma, recurrent and/or metastatic",

author = "{ESMO Guidelines Committee} and P. Bossi and Chan, {A. T.} and C. Even and Machiels, {J. P.}",

year = "2023",

month = mar,

day = "1",

doi = "10.1016/j.annonc.2022.11.011",

language = "English",

volume = "34",

pages = "247--250",

journal = "Annals of Oncology",

issn = "0923-7534",

number = "3",

}

TY - JOUR

T1 - ESMO–EURACAN Clinical Practice Guideline update for nasopharyngeal carcinoma

T2 - adjuvant therapy and first-line treatment of recurrent/metastatic disease

AU - ESMO Guidelines Committee

AU - Bossi, P.

AU - Chan, A. T.

AU - Even, C.

AU - Machiels, J. P.

PY - 2023/3/1

Y1 - 2023/3/1

KW - adjuvant

KW - capecitabine

KW - Clinical Practice Guideline

KW - immunotherapy

KW - nasopharyngeal carcinoma

KW - recurrent and/or metastatic

UR - http://www.scopus.com/inward/record.url?scp=85148678154&partnerID=8YFLogxK

U2 - 10.1016/j.annonc.2022.11.011

DO - 10.1016/j.annonc.2022.11.011

M3 - Article

C2 - 36529446

AN - SCOPUS:85148678154

SN - 0923-7534

VL - 34

SP - 247

EP - 250

JO - Annals of Oncology

JF - Annals of Oncology

IS - 3

ER -